Financing channel feed – Endpoints News

Financing channel feed

Flagship plants next bet on chronic diseases with ex-Ancestry CEO at the helm

3 years ago

ImmunityBio looks to pull in $157M from founder Patrick Soon-Shiong and another investor

3 years ago

Black Diamond spins out antibody work into new biotech with $30M from Versant, NEA

3 years ago

Replimune looks to rope in $225M on the back of melanoma data

3 years ago

Erasca delves further into RAS/MAPK with Novartis drug, prices $100M offering

3 years ago

Scoop: Stephen Squinto’s Yale spinout is raising a Series B for genetic medicines

3 years ago

Autolus tips its hand, bags $220M as CAR-T showdown with Gilead looms

3 years ago

Nashville-based CDMO nets a $65M Series B to expand facility and capabilities

3 years ago

Nearly out of cash, a former Sarepta partner asks French courts to oversee restructuring

3 years ago

Priming therapy biotech emerges from stealth with seed funding — and on a hunt for partners

3 years ago

Prometheus moves to raise cash hours after PhII data leads to stock surge

3 years ago

Just days before presenting at ASH conference, Syndax outlines plan to raise $150M

3 years ago

Penny stock pulls back on offering up more of its shares amid ‘current market conditions’

3 years ago

They withdrew their IPO. Then, they broke off their SPAC merger. Now what?

3 years ago

Former BridgeBio exec launches new anti-inflammatory biotech with $169M, but is mum on what exactly it's doing

3 years ago

Bouncing from major setback, Summit hands out $500M cash for cancer drug — thanks to a loan from billionaire CEO

3 years ago

AbbVie puts up $40M to license a treatment from HotSpot Therapeutics

3 years ago

Scoop: Avalon, MPM back new CNS biotech with scientific chops from Astellas

3 years ago

Avalon Ventures spins off a separate fund to handle life science companies — armed with $135M

3 years ago

A new Vega enters the galaxy with bleeding disorder antibody set for 2023 trial

3 years ago

Entact Bio makes its Series A debut with $81M to launch protein enhancement platform

3 years ago

Pfizer-backed Mediar Therapeutics ropes in another Big Pharma investor

3 years ago

Gene therapy goes acoustic as ARCH-backed biotech launches with ultrasound gene delivery platform

3 years ago

Vertex-partnered gene therapy biotech Affinia scraps IPO plans

3 years ago

First page Previous page 41 42 434445 46 47 Next page Last page